Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01637077 · ClinicalTrials.gov registry record · Phase 2
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
A Phase 2 study of Pain and Peripheral Neuropathy, sponsored by Academic and Community Cancer Research United.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
- 6
- Study locations
NCT01637077: Completed Phase 2 study of Pain and Peripheral Neuropathy, sponsored by Academic and Community Cancer Research United.
NCT01637077 is a Phase 2 study of Pain and Peripheral Neuropathy that has completed, run by Academic and Community Cancer Research United. The registered enrollment target is 46 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01637077, a Phase 2 study of Pain and Peripheral Neuropathy, has completed, sponsored by Academic and Community Cancer Research United.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
- 6
- Study locations
Study Summary
This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.
Primary Outcome
Worst of the pain scores for the week following the first cycle of paclitaxel administration, as measured by a question on the daily post-paclitaxel questionnaire. Worst pain over the first 6 days following treatment initiation. Higher scores represent more pain (0: No aches or pains -10: Aches or pains as bad as can be).
Conditions Studied
Interventions
- DRUG placebo
- OTHER questionnaire administration
- DRUG pregabalin
Study Locations (6)
Minnesota
- Essentia Health-Duluth CCOP - Duluth
- Mayo Clinic - Rochester
- Coborn Cancer Center at Saint Cloud Hospital - Saint Cloud
Kansas
- Cancer Center of Kansas - Wichita
Nebraska
- Missouri Valley Cancer Consortium - Omaha
Wisconsin
- Marshfield Clinic - Marshfield Center - Marshfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
What the finished NCT01637077 record still lists
NCT01637077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.
NCT01637077 lists 6 locations in 4 states (Minnesota, Kansas, Nebraska).
Frequently Asked Questions
What is clinical trial NCT01637077 about?
NCT01637077 is a clinical study titled "Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel". This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.
What is the current status of trial NCT01637077?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2012-01. Estimated completion is 2016-04.
What conditions does trial NCT01637077 study?
This clinical trial studies the following conditions: Pain, Peripheral Neuropathy.
What interventions are being tested in trial NCT01637077?
The interventions under investigation include: placebo (DRUG), questionnaire administration (OTHER), pregabalin (DRUG).
Who is sponsoring clinical trial NCT01637077?
This trial is sponsored by Academic and Community Cancer Research United, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01637077 being conducted?
This trial has 6 study locations across Kansas, Minnesota, Nebraska, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01637077's enrollment target sits among peer trials
46 268th of 374 higher than 104 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Pain After Buffered Vs Non Buffered Articaine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia